GlassScriptPhysician profile
Ralph Laraiso
NPI 1699770842
$698.56
in general payments reported to CMS, 2019-2025
12 companies · $77.37 in 2025
The $77.37 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $80.06 · 2022: $229 · 2023: $51.50 · 2025: $77.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $128.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $166.74 | 2019-2022 | |
| Nevro Corp. | $110.01 | 2020-2023 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $109.11 | 2019-2022 | |
| Biodelivery Sciences International, INC. | $73.34 | 2019 | |
| Pfizer INC. | $63.18 | 2019 | |
| Grt US Holding, INC. | $45.00 | 2022 | |
| Tandem Diabetes Care, INC. | $34.37 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Janssen Biotech, INC. | $22.52 | 2025 | Tremfya |
| Averitas Pharma INC. | $21.55 | 2023 | Qutenza |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Aimmune Therapeutics, INC. | $20.48 | 2025 | Vowst |
| Medtronic USA, INC. | $11.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Laraiso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.